MedTrace Logo

Correction of Myopia Evaluation Trial (COMET)

NCT00000113 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 469

Last updated 2016-04-15

No results posted yet for this study

Summary

To evaluate whether progressive addition lenses (PALs) slow the rate of progression of juvenile-onset myopia (nearsightedness) when compared with single vision lenses, as measured by cycloplegic autorefraction. An additional outcome measure is axial length, as measured by A-scan ultrasonography.

To describe the natural history of juvenile-onset myopia in a group of children receiving conventional treatment (single vision lenses).

Conditions

  • Myopia

Interventions

OTHER

Progressive Addition Lenses

Varilux comfort with +2.00 addition

OTHER

single vision lenses

Sponsors & Collaborators

Principal Investigators

  • Jane Gwiazda, PhD · New England College of Optometry

  • Leslie Hyman, PhD · Stony Brook Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1997-09-30
Primary Completion
2001-10-31
Completion
2013-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00000113 on ClinicalTrials.gov